SCHEMBL10069045

SCHEMBL10069045

COC(=O)c1cc(C(O)c2cccc(Cl)c2)cc(S(C)(=O)=O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 1/20 0.43
ADORA2A P29274 1/20 0.43
ADORA2B P29275 1/20 0.43
ADORA1 P30542 1/20 0.43
ADRB2 P07550 1/20 0.41
ADRB1 P08588 1/20 0.41
ADRB3 P13945 1/20 0.41
PTGS2 P35354 2/20 0.41
ALDH1A1 P00352 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA9 Q16790 2/20 0.40
CA12 O43570 1/20 0.40
CA14 Q9ULX7 1/20 0.40
GAA P10253 1/20 0.40
POLB P06746 2/20 0.39
AKR1C3 P42330 2/20 0.38
AKR1C2 P52895 1/20 0.38
AKR1C1 Q04828 1/20 0.38
GFER P55789 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10069563 0.87 ADRB2 (0.47) ADRB2ADRB1ADRB3ALDH1A1POLB
SCHEMBL1568650 0.83 ADRB2 (0.54) ADRB2ADRB1ADRB3ALDH1A1GAA
SCHEMBL10069574 0.83 PTGER4 (0.45) ADRB2ADRB1ADRB3POLBGFER
SCHEMBL10068535 0.83 CA12 (0.49) ADRB2ADRB1ADRB3CA1CA2
SCHEMBL10069315 0.81 ADRB1 (0.43) ADRB2ADRB1ADRB3ALDH1A1CA1
SCHEMBL10069566 0.81 ADRB1 (0.45) ADRB2ADRB1ADRB3POLBGFER
SCHEMBL10068713 0.80 ADRB3 (0.49) ADRB2ADRB1ADRB3PPARASLC6A3
SCHEMBL8993085 0.79 ADRB3 (0.50) ADRB2ADRB1ADRB3ALDH1A1CA1
SCHEMBL10069036 0.78 HTT (0.38) ADORA3ADORA2AADORA2BADORA1ADRB2
SCHEMBL10069336 0.78 SLC6A3 (0.43) ADRB2ADRB1ADRB3POLBGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012019428-A1 BENZOHYDROL DERIVATIVES, A PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF 上海恒瑞医药有限公司 (CN) 2012-02-16 WO disclosed